Methyl 4-Bromo-2,5-Dimethyl-1H-Pyrrole-3-Carboxylate

Kinase Inhibitor Fragment Synthesis via Palladium-Mediated Cross-Coupling

In kilogram-scale synthesis of pyrrolo[2,3-d]pyrimidine kinase inhibitor candidates, methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate functions as a C4-building block introduced in a controlled Suzuki-Miyaura coupling sequence. The bromo substituent positioned para to the ester group undergoes oxidative insertion with Pd(0) while the 2,5-dimethyl substituents provide steric shielding that suppresses homocoupling side reactions and limits protodebromination to <2%. A validated manufacturing protocol charges 1.0–1.05 equivalents of the bromopyrrole ester relative to the arylboronic acid coupling partner in a degassed ternary solvent system of toluene, ethanol, and aqueous 2 M potassium carbonate at a 3:1:1 volumetric ratio. The reaction is conducted in a 2,000 L glass-lined vessel fitted with a retreat-curve impeller and a nitrogen sparge ring; after inertion to <0.5 vol% oxygen, tetrakis(triphenylphosphine)palladium(0) (0.5 mol% vs. bromide) is injected as a pre-dissolved toluene solution. The biphasic mixture is heated to 78–82 °C and held until HPLC monitoring (C18, acetonitrile/0.1% TFA gradient, detection at 254 nm) shows residual aryl halide below 0.5 area%, typically 6–10 hours. Quenching with 1% aqueous N-acetylcysteine followed by phase separation and vacuum distillation yields the biaryl intermediate, which is crystallized from isopropanol/water to afford an off-white solid with >99.0% HPLC purity. The entire operation complies with ICH Q7 Sections 5.3 (equipment cleaning validation), 7.3 (incoming material identity testing via FTIR and ¹H NMR), and 12 (process validation for materials intended as regulatory starting materials). Residual palladium is controlled below 20 ppm by ICP-MS and residual solvents meet USP <467> Option 1. The terminal output of the process is a library of elaborated biaryl intermediates that serve as precursors to ATP-competitive BTK, JAK2, and FGFR inhibitors currently in preclinical evaluation; the same core scaffold can be advanced to cGMP intermediates when coupled with a downstream Boc-protection/hydrolysis sequence.

What Drives Stability in Arylpyrrole Acaricide Production Using Halogenated Pyrrole Ester Intermediates

For the synthesis of contact acaricides and insecticidal mitochondrial uncouplers related to the chlorfenapyr chemotype, methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate is transformed into the corresponding nitrile or carboxamide through a two-vessel sequence that demands rigorous control of exotherm and alkali concentration. In a 5,000 L enamel reactor, the pyrrole ester is saponified with 25% aqueous sodium hydroxide at a controlled addition rate to maintain a processing temperature of 55–60 °C; tip speed of the pitched-blade agitator is sustained above 2.5 m/s to prevent sodium salt caking that otherwise leads to hot spots and ester cleavage at the 3-position. The resulting sodium carboxylate is acidified with 30% hydrochloric acid to pH 2.8–3.2, and the free acid is isolated via a horizontal peeler centrifuge operated at 900 G, washed until conductivity of the filtrate falls below 50 µS/cm, and dried in a double-cone rotary vacuum dryer at 45 °C/10 mbar until Karl Fischer moisture reads <0.5 wt%. The dried acid is subsequently converted to the amide via SOCl₂-mediated chlorination in toluene at 0–5 °C followed by quenching into anhydrous ammonia gas, yielding an intermediate that on condensation with ethoxymethyl chloride and trifluoroacetic anhydride delivers the arylpyrrole acaricide scaffold. The bromopyrrole ester input typically accounts for 30–35 wt% of the initial batch charge and its purity specification (≥99.0%, single impurity <0.3%) is critical to prevent accumulation of des-bromo byproducts that co-distill during final purification. Regulatory compliance for exported technical grade materials requires adherence to FAO/WHO Joint Meeting on Pesticide Specifications (JMPS) for active ingredient identity, with impurity thresholds for hexachlorobenzene-type contaminants set at <50 mg/kg. Production sites supplying intermediates to this value chain also hold ISO 14001:2015 environmental management certification and operate under EU REACH (EC) No 1907/2006 registration dossiers that include full toxicological profiles for the bromopyrrole ester as a non-isolated intermediate under strictly controlled conditions.

When Halogenated Pyrrole Esters Are Used to Modulate Hole Transport in OLED Devices

Vacuum-deposited phosphorescent organic light-emitting diodes with external quantum efficiencies exceeding 25% frequently incorporate a p-dopant layer to lower the hole injection barrier, and methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate can be converted into a deep-HOMO transport material via sequential Buchwald-Hartwig amination and ester saponification. In a typical pilot-scale run, the bromopyrrole ester (1.0 eq) is reacted with 4,4'-dimethoxydiphenylamine (1.05 eq) in anhydrous toluene under a positive argon atmosphere in the presence of Pd₂(dba)₃ (0.5 mol% Pd) and NiXantphos ligand (1.1 mol%) at 110 °C for 18 hours. After workup with aqueous EDTA to sequester palladium and filtration through a 0.2 µm PTFE membrane, the crude amine is hydrolyzed with lithium hydroxide monohydrate in THF/water (3:1 v/v) at 0–5 °C to liberate the free acid, which is subsequently acidified and isolated as a pale yellow powder. The critical purification step for electronic-grade material is vacuum train sublimation: the acid is loaded into a single-zone quartz boat and sublimed at 240 °C/10⁻⁶ Torr with a deposition rate controlled at 0.3–0.5 Å/s onto a cooled substrate to achieve a non-volatile residue content below 0.05 wt% and HPLC area 99.95%. The resulting molecular dopant, when co-evaporated with an arylamine host at a concentration of 0.5–2.0 wt%, shifts the Fermi level toward the HOMO by 0.35–0.50 eV as measured by ultraviolet photoelectron spectroscopy (UPS) on a 100 nm co-deposited film. The metal ion specification follows SEMI C43-0319, requiring each of Na, K, Ca, Fe, and Zn to remain below 10 ppb as determined by droplet scan ICP-MS on a digested sample; any batch exceeding 25 ppb total metals is automatically failed. OLED stacks incorporating this dopant in the hole transport layer have been demonstrated to lower the driving voltage by 0.7 V at 10 mA/cm² relative to an undoped device, with no detectable luminescence quenching at doping levels up to 3 wt%.

For high-performance organic pigment Yellow 139 derivatives and related isoindolinone pigments that require a coplanar biaryl chromophore, methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate provides a bridging bromine that enables palladium-catalyzed C–C bond formation with electron-deficient aryltriflates or iodides under conditions that preserve the hydrolytically sensitive methyl ester. The addition ratio in the pigment synthesis step is precisely stoichiometric: 1.00 equivalent of the bromopyrrole ester is coupled with 1.02 equivalent of the aryl halide or pseudo-halide in a dimethylacetamide/toluene mixture at 105 °C using Pd(OAc)₂/SPhos (1.5 mol%) and potassium phosphate tribasic as base. The reaction mass is diluted with methanol and the precipitated crude pigment is subjected to solvent-assisted milling in a horizontal bead mill charged with 0.6 mm yttria-stabilised zirconia beads operating at 14 m/s tip speed, followed by acidic after-treatment at 95 °C in 5% sulfuric acid to shift the crystal phase to the desired high-opacity polymorph. The finished pigment, which incorporates the pyrrole-derived fragment as a key hue-altering substructure, displays a CIELAB hue angle of 86–90°, heat stability up to 280 °C, and is targeted for use in coil coatings and powder coatings requiring QUV-B weathering resistance (ASTM G154-23, 500 h ΔE <2.0). Compliance for export of such pigment intermediates demands adherence to ISO 787-5 for oil absorption and ISO 787-16 for relative tinting strength, and a REACH registration under the pigment intermediate tonnage band. The bromopyrrole ester lot-to-lot consistency is monitored by quantitative ¹³C NMR to ensure that the positional purity at the 4-bromo site exceeds 99.5%, because isomeric impurities cause visible shade drift in the final pigmented formulation.

Unlike standard radical-initiated grafting procedures for maleic anhydride copolymers, the direct amidation of poly(styrene-co-maleic anhydride) (SMA) with methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate achieves pendant bromopyrrole functionality that later serves as a fluorescence reporting site or a halogen-exchange handle for further functionalization. The grafting reaction is executed in a co-rotating twin-screw extruder with an L/D of 40 and nine barrel zones, where the pre-dried SMA resin (forced-air oven, 80 °C, 4 h, moisture <0.08%) is fed into the main hopper while the liquid bromopyrrole ester is injected via a heated gear pump into zone 4 at a mass flow setpoint delivering 1.5–3.0 mol% relative to the maleic anhydride repeat units. The screw configuration includes a downstream kneading block section to generate elongational mixing sufficient to push the amidation conversion above 92% (tracked by acid number reduction per ASTM D3644-22), while barrel temperatures are maintained at 165–195 °C to avoid thermal dehydrobromination side reactions that accelerate at processing temperatures above 205 °C. Pelletized graft copolymer is subsequently characterized by GPC (eluent THF, polystyrene standards) to confirm a monomodal distribution without crosslink-related shoulders, and by differential scanning calorimetry which reveals a glass transition depression of 3–6 °C relative to the parent SMA attributed to the bulky pyrrole side groups. The functionalized pellets are injection molded into test plaques on a 110-ton press with mold temperature 40 °C; these plaques exhibit strong blue fluorescence under 365 nm excitation and are qualified as brand-protection taggants for extruded polyolefin films under ISO 18314-1:2015. Although the modified copolymer is not intended for food contact, migration testing according to EN 1186-1:2002 with 3% acetic acid and 10% ethanol simulants is performed to support a safety dossier for incidental mouth contact applications, with a detection limit of 0.05 µg/dm².

In activity-based protein profiling (ABPP) workflows targeting glutathione S-transferase (GST) isoforms, the methyl 4-bromo-2,5-dimethyl-1H-pyrrole-3-carboxylate scaffold serves as a masked electrophilic warhead: the methyl ester is selectively hydrolyzed under physiological conditions (PBS buffer, pH 7.4, 37 °C) by incubating the probe-conjugate with the target lysate for 30 min, generating a carboxylic acid that then engages a nucleophilic active-site serine or cysteine residue as documented in competitive ABPP assays against commercially available fluorescent probes. The synthetic assembly of the probe begins with a solution-phase coupling—1.0 eq bromopyrrole ester is activated with HOBt (1.2 eq) and EDC·HCl (1.1 eq) in anhydrous DMF at 0–5 °C for 40 minutes, then combined with a heterobifunctional PEG₈ diamine (0.95 eq to ensure full end-functionalization) and stirred under argon for 16 h while warming to 20 °C. After aqueous workup and flash chromatography (silica, dichloromethane/methanol 9:1), the PEGylated intermediate is conjugated to an alkyne-bearing biotin tag through copper-catalyzed azide-alkyne cycloaddition (CuAAC, TBTA/5 mol% CuSO₄/sodium ascorbate, RT, 2 h). The addition ratio in the final ABPP probe construct is defined by gravimetric preparation of a 10 mM DMSO stock solution that is dispensed into assay plates with a liquid handler calibrated to ±0.5% volumetric precision; batch-to-batch probe concentration is verified by UV absorbance at 280 nm against an extinction coefficient determined by amino acid analysis. Production and QC follow the research-grade requirements of ISO 9001:2015 with incoming bromopyrrole ester acceptance criteria of ≥99.15% purity and endotoxin levels below 0.25 EU/mg for cellular assay compatibility. The terminal output is a suite of functionalized pyrrole probes used for target engagement studies in human hepatocyte lysates, enabling differentiation of GST-π from GST-μ isoforms and providing an alternative scaffold to the widely used chloromethylketone and fluorophosphonate chemotypes.